BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyadera K, Conatser L, Llanga TA, Carlin K, O'Donnell P, Bagel J, Song L, Kurtzberg J, Samulski RJ, Gilger B, Hirsch ML. Intrastromal Gene Therapy Prevents and Reverses Advanced Corneal Clouding in a Canine Model of Mucopolysaccharidosis I. Mol Ther 2020;28:1455-63. [PMID: 32330426 DOI: 10.1016/j.ymthe.2020.04.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Tian B, Bilsbury E, Doherty S, Teebagy S, Wood E, Su W, Gao G, Lin H. Ocular Drug Delivery: Advancements and Innovations. Pharmaceutics 2022;14:1931. [DOI: 10.3390/pharmaceutics14091931] [Reference Citation Analysis]
2 Lee JY, Han SB. Case report of transient corneal edema after immunization with adenovirus-vectored COVID-19 vaccine. Medicine (Baltimore) 2022;101:e30041. [PMID: 35866821 DOI: 10.1097/MD.0000000000030041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mohan RR, Kempuraj D, D'souza S, Ghosh A. Corneal stromal repair and regeneration. Progress in Retinal and Eye Research 2022. [DOI: 10.1016/j.preteyeres.2022.101090] [Reference Citation Analysis]
4 Park S, Sebbag L, Moore BA, Casanova MI, Leonard BC, Daley NL, Steele KA, Li JY, Murphy CJ, Thomasy SM. Multimodal ocular imaging of known and novel corneal stromal disorders in dogs. BMC Vet Res 2022;18. [DOI: 10.1186/s12917-022-03214-7] [Reference Citation Analysis]
5 Zhang X, Chai Z, Lee Dobbins A, Itano MS, Askew C, Miao Z, Niu H, Samulski RJ, Li C. Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain. Biomaterials 2021;281:121340. [PMID: 34998171 DOI: 10.1016/j.biomaterials.2021.121340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Su W, Sun S, Tian B, Tai PWL, Luo Y, Ko J, Zhan W, Ke X, Zheng Q, Li X, Yan H, Gao G, Lin H. Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics. Mol Ther Methods Clin Dev 2021;22:107-21. [PMID: 34514023 DOI: 10.1016/j.omtm.2021.06.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Song L, Samulski RJ, Hirsch ML. Adeno-Associated Virus Vector Mobilization, Risk Versus Reality. Hum Gene Ther 2020;31:1054-67. [PMID: 32829671 DOI: 10.1089/hum.2020.118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Entchev E, Antonelli S, Mauro V, Cimbolini N, Jantzen I, Roussey A, Germain JM, Zhang H, Luccarrini JM, Lacombe O, Young SP, Feraille L, Tallandier M. MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment. Mol Genet Metab 2021:S1096-7192(21)00759-9. [PMID: 34417096 DOI: 10.1016/j.ymgme.2021.07.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 McGrath O, Au L, Ashworth J. Management of Corneal Clouding in Patients with Mucopolysaccharidosis. J Clin Med 2021;10:3263. [PMID: 34362047 DOI: 10.3390/jcm10153263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Korecki AJ, Cueva-Vargas JL, Fornes O, Agostinone J, Farkas RA, Hickmott JW, Lam SL, Mathelier A, Zhou M, Wasserman WW, Di Polo A, Simpson EM. Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells. Gene Ther 2021;28:351-72. [PMID: 33531684 DOI: 10.1038/s41434-021-00227-z] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Hampe CS, Wesley J, Lund TC, Orchard PJ, Polgreen LE, Eisengart JB, McLoon LK, Cureoglu S, Schachern P, McIvor RS. Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement. Biomolecules 2021;11:189. [PMID: 33572941 DOI: 10.3390/biom11020189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
12 Bastola P, Song L, Gilger BC, Hirsch ML. Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases. Pharmaceutics 2020;12:E767. [PMID: 32823625 DOI: 10.3390/pharmaceutics12080767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Puri S, Coulson-Thomas YM, Gesteira TF, Coulson-Thomas VJ. Distribution and Function of Glycosaminoglycans and Proteoglycans in the Development, Homeostasis and Pathology of the Ocular Surface. Front Cell Dev Biol 2020;8:731. [PMID: 32903857 DOI: 10.3389/fcell.2020.00731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
14 Song L, Bower JJ, Llanga T, Salmon JH, Hirsch ML, Gilger BC. Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits. Mol Ther Methods Clin Dev 2020;18:24-32. [PMID: 32542182 DOI: 10.1016/j.omtm.2020.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]